Verisante TechnologyVRSEF 14-Day RSI is 10.25 as of Jul. 07, 2026. Among 870 Medical Devices & Instruments companies, Verisante Technology ranks better than 88.39% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Verisante Technology 14-Day RSI Related Terms
VRSEF vs ABT, SYK, MDT: 14-Day RSI Comparison
For the Medical Devices subindustry, Verisante Technology's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verisante Technology 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Verisante Technology's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Verisante Technology's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verisante Technology (VRSEF) has a 14-Day RSI of 10.25 as of Jul. 07, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Verisante Technology and its competitors. According to the industry distribution chart, Verisante Technology ranks #101 out of 870 companies in the Medical Devices & Instruments industry, placing it in the top 11.6%.
Is Verisante Technology's 14-Day RSI too high?
Verisante Technology's current 14-Day RSI is 10.25. The Medical Devices & Instruments industry median 14-Day RSI is 49.73. Verisante Technology's value of 10.25 is 79.4% below this industry median. Based on the distribution chart, Verisante Technology ranks #101 out of 870 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Verisante Technology's 14-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Verisante Technology ranks #101 out of 870 companies for 14-Day RSI. This places Verisante Technology in the top 12% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 49.73. Verisante Technology's value of 10.25 is 79.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 49.73, based on 870 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Verisante Technology's current 14-Day RSI of 10.25 is 79.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Verisante Technology and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 49.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verisante Technology's current 14-Day RSI is 10.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verisante Technology stock overvalued right now?
Verisante Technology (VRSEF) has a current 14-Day RSI of 10.25. The current 14-Day RSI is 10.25 and 79.4% below the Medical Devices & Instruments industry median of 49.73. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Verisante Technology (VRSEF), the current 14-Day RSI is 10.25 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Verisante Technology Inc does not have any operations. It is currently seeking out opportunities to acquire a successful business such as a provider of cutting-edge technologies and services, offering scalable solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRSEF has been successfully added to your